One of the prominent organs differentiating between males & females is the reproductive organs in their bodies. In females, ovaries are the two reproductive glands present in the body of a female that produces eggs & female hormones called estrogen & progesterone.
Over the years, the population of females has improved across different corners of the world due to a gradual decline in cases of crimes like female foeticide & infanticide. However, different challenges associated with females are yet to progress. While the world is now accepting females as equals to males, some regions, especially the population with a backward mentality in rural areas, still overlook equality and do not even provide the basic rights to proper health. As a result, numerous health complications in females are overlooked, which become a core reason behind their deaths.
Undoubtedly, the world is developing at a rapid pace and showcasing advancements in different fields, including medical sciences. It, in turn, is generating accessibility for the females to check up and attain the medical attention they deserve. In fact, the governments of different countries around the world are encouraging the same, and spreading awareness about the presence of deadly diseases and the availability of cures & treatment of the same, in the hope to reduce the cases and offer better lives to the people.
Among the different types of health conditions, in females, ovarian cancer is becoming very common and affecting their lives severely. A recent research study has predicted double-digit growth for the Global Ovarian Cancer Market during 2022-27 in terms of drug sales, on account of the growing availability of effective diagnosis & treatments, i.e., bringing hope for a better life to females. The severity of cancers is so deadly that among all types of cancers in females, ovarian cancers are one of the prominent causes of death. It occurs when the body develops abnormal cell growth in the ovary & multiples uncontrollably, forming a tumor.
The most prominent causes of increased deaths due to ovarian cancers are the late diagnosis & improper treatment of the disease. Although, affordability is another aspect that restraints success in the treatment, governments of different countries worldwide are investing substantially in various research & developments on finding highly effective & affordable therapies for ovarian cancer while imposing favorable norms for biopharma companies to conduct clinical trials of novel drugs.
Ovarian cancer has various warning signs, even though the early signs are vague & are often dismissed. It is one of the many reasons why, in most cases, such cancers are diagnosed at later stages instead of early. Let us take a look at the various signs & symptoms of Ovarian cancer in the blog.
Ovarian Cancer Signs & Symptoms
While a majority of the females detect their symptoms at the later stages, a few early signs of ovarian cancer is listed below.
While these are some of the early signs of ovarian cancer, similar ones are also seen in females suffering from benign conditions, where the ovary develops the growth of functional cysts & tumors. Hence, it is highly important to understand that such symptoms & signs in ovarian cancer are persistent, and show noticeable changes in typical, day-to-day sensations. Following are some possible signs & symptoms of ovarian cancers during their later stages:
These symptoms would be persistent, where there is ovarian cancer and would become severe as the tumor grows, spreading outside of the ovaries and making it difficult to treat effectively. The most difficult in cancer is the diagnosis in the severe stages. This is a stage where some females tend to develop the following signs:
Since the possibility of getting ovarian cancer is irrespective of the age, many signs & symptoms of this cancer are also seen during the post-menopausal stage in females. Although most of these symptoms are similar to the others, what remains a differentiation is Bleeding.
After reaching the menopause stage, periods are no longer a part of life in females. However, if the person notices bleeding after menopause, it could be a sign of ovarian cancer. In fact, this cancer is more common in females over the age of 60.
How are the Coming Years for the Ovarian Cancer Market?
Governments of several countries worldwide are spreading awareness about ovarian cancer and its effective diagnosis & treatment available. With the rising penetration of Olaparib, Rucaparib, & Niraparib, the introduction of Jemperli (dostarlimab) & Opdivo (nivolumab), and as novel therapies complete their trials & get past regulatory agencies, the Global Ovarian Cancer Market would notably expand in the future, and the US will become the fastest-growing ovarian cancer market.
